Literature DB >> 12023018

Degradation of human Aurora-A protein kinase is mediated by hCdh1.

Sei ichi Taguchi1, Kei Honda, Kazumitsu Sugiura, Akio Yamaguchi, Koichi Furukawa, Takeshi Urano.   

Abstract

Human Aurora-A is related to a protein kinase originally identified by its close homology to Ipl1p from Saccharomyces cerevisiae and aurora from Drosophila melanogaster, which are key regulators of the structure and function of the mitotic spindle. We previously showed that human Aurora-A is turned over through the anaphase promoting complex/cyclosome (APC/C)-ubiquitin-proteasome pathway. The association of two distinct WD40 repeat proteins known as Cdc20 and Cdh1, respectively, sequentially activates the APC/C. The present study shows that Aurora-A degradation is dependent on hCdh1 in vivo, not on hCdc20, and that Aurora-A is targeted for proteolysis through distinct structural features of the destruction box, the KEN box motifs and its kinase activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023018     DOI: 10.1016/s0014-5793(02)02711-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  38 in total

Review 1.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

2.  Control of Aurora-A stability through interaction with TPX2.

Authors:  Maria Giubettini; Italia A Asteriti; Jacopo Scrofani; Maria De Luca; Catherine Lindon; Patrizia Lavia; Giulia Guarguaglini
Journal:  J Cell Sci       Date:  2010-12-08       Impact factor: 5.285

3.  Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property.

Authors:  Hao G Nguyen; Dharmaraj Chinnappan; Takeshi Urano; Katya Ravid
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  A G-quadruplex stabilizer induces M-phase cell cycle arrest.

Authors:  Yuan-Chin Tsai; Haiyan Qi; Chao-Po Lin; Ren-Kuo Lin; John E Kerrigan; Suzanne G Rzuczek; Edmond J LaVoie; Joseph E Rice; Daniel S Pilch; Yi Lisa Lyu; Leroy F Liu
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

5.  Mitotic regulation of the stability of microtubule plus-end tracking protein EB3 by ubiquitin ligase SIAH-1 and Aurora mitotic kinases.

Authors:  Reiko Ban; Hideki Matsuzaki; Tomohiro Akashi; Gyosuke Sakashita; Hisaaki Taniguchi; Sam-Yong Park; Hirofumi Tanaka; Koichi Furukawa; Takeshi Urano
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

6.  Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A.

Authors:  Yan Shi; Larry R Solomon; Ana Pereda-Lopez; Vincent L Giranda; Yan Luo; Eric F Johnson; Alexander R Shoemaker; Joel Leverson; Xuesong Liu
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

Review 7.  TPX2: of spindle assembly, DNA damage response, and cancer.

Authors:  Gernot Neumayer; Camille Belzil; Oliver J Gruss; Minh Dang Nguyen
Journal:  Cell Mol Life Sci       Date:  2014-02-21       Impact factor: 9.261

8.  NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.

Authors:  Ryan J Ice; Sarah L McLaughlin; Ryan H Livengood; Mark V Culp; Erik R Eddy; Alexey V Ivanov; Elena N Pugacheva
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

Review 9.  Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity.

Authors:  Christopher L Frank; Li-Huei Tsai
Journal:  Neuron       Date:  2009-05-14       Impact factor: 17.173

Review 10.  Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins.

Authors:  Mar Carmena; Sandrine Ruchaud; William C Earnshaw
Journal:  Curr Opin Cell Biol       Date:  2009-12       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.